| Analysis | Metabolite Name | Measured Value | Units | Brain region | Gender |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 1092627 | Peak height | Cerebellum | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 1810377 | Peak height | Medulla | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 1843463 | Peak height | Basal ganglia | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 1921111 | Peak height | Basal ganglia | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 1951175 | Peak height | Pons | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 1963046 | Peak height | Basal ganglia | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2015594 | Peak height | Hippocampus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2073016 | Peak height | Cerebellum | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2118091 | Peak height | Pons | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2185733 | Peak height | Medulla | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2188728 | Peak height | Medulla | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2225050 | Peak height | Cerebellum | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2280417 | Peak height | Hippocampus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2313416 | Peak height | Hippocampus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2327213 | Peak height | Cerebellum | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2415787 | Peak height | Hippocampus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2454634 | Peak height | Hippocampus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2460308 | Peak height | Cerebellum | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2460737 | Peak height | Hippocampus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2466982 | Peak height | Medulla | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2478545 | Peak height | Medulla | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2499003 | Peak height | Medulla | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2529638 | Peak height | poolQC | - |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2582077 | Peak height | Cerebellum | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2590442 | Peak height | Cerebellum | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2595366 | Peak height | Thalamus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2608907 | Peak height | Basal ganglia | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2663674 | Peak height | Hippocampus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2705754 | Peak height | Hippocampus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2750581 | Peak height | poolQC | - |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2751359 | Peak height | Cerebellum | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2756565 | Peak height | poolQC | - |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2761570 | Peak height | poolQC | - |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2763518 | Peak height | Cerebral cortex | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2765363 | Peak height | poolQC | - |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2770521 | Peak height | Cerebellum | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2774251 | Peak height | poolQC | - |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2775970 | Peak height | poolQC | - |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2779937 | Peak height | poolQC | - |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2797013 | Peak height | Cerebral cortex | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2798125 | Peak height | poolQC | - |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2800419 | Peak height | poolQC | - |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2814559 | Peak height | poolQC | - |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2818511 | Peak height | Medulla | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2820052 | Peak height | Cerebellum | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2821787 | Peak height | poolQC | - |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2828671 | Peak height | poolQC | - |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2833483 | Peak height | poolQC | - |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2842936 | Peak height | Cerebellum | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2849902 | Peak height | Medulla | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2855739 | Peak height | Basal ganglia | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2887556 | Peak height | Hippocampus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2895291 | Peak height | Hippocampus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2914389 | Peak height | Hippocampus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2916617 | Peak height | Cerebellum | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2987296 | Peak height | Basal ganglia | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2990467 | Peak height | Basal ganglia | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2992531 | Peak height | Cerebral cortex | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2999409 | Peak height | Hippocampus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3011603 | Peak height | Cerebral cortex | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3021264 | Peak height | Cerebellum | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3032852 | Peak height | Cerebral cortex | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3037138 | Peak height | poolQC | - |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3077408 | Peak height | Medulla | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3079976 | Peak height | Medulla | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3109233 | Peak height | Hippocampus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3113705 | Peak height | Cerebral cortex | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3120789 | Peak height | Pons | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3121563 | Peak height | Basal ganglia | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3127784 | Peak height | Medulla | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3179562 | Peak height | Cerebral cortex | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3192596 | Peak height | Cerebral cortex | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3235183 | Peak height | Basal ganglia | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3273121 | Peak height | Cerebellum | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3274849 | Peak height | Cerebellum | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3365115 | Peak height | Medulla | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3400486 | Peak height | Pons | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3442723 | Peak height | Medulla | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3465037 | Peak height | Medulla | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3508810 | Peak height | Hippocampus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3534433 | Peak height | Basal ganglia | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3537303 | Peak height | Cerebral cortex | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3544153 | Peak height | Cerebral cortex | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3549915 | Peak height | Hippocampus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3579970 | Peak height | Cerebral cortex | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3586525 | Peak height | Medulla | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3633935 | Peak height | Pons | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3680751 | Peak height | Hypothalamus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3688167 | Peak height | Thalamus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3694291 | Peak height | Pons | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3729393 | Peak height | Basal ganglia | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3757528 | Peak height | Pons | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3812743 | Peak height | Cerebral cortex | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3823120 | Peak height | Pons | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3842417 | Peak height | Thalamus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3854493 | Peak height | Hippocampus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3869834 | Peak height | Hypothalamus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3870641 | Peak height | Cerebral cortex | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3912652 | Peak height | Pons | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3930641 | Peak height | Pons | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3933466 | Peak height | Hypothalamus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3978345 | Peak height | Basal ganglia | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4000077 | Peak height | Pons | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4019113 | Peak height | Hypothalamus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4054587 | Peak height | Cerebral cortex | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4059519 | Peak height | Pons | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4099271 | Peak height | Midbrain | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4129169 | Peak height | Midbrain | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4135823 | Peak height | Midbrain | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4142631 | Peak height | Hypothalamus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4144536 | Peak height | Hypothalamus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4160140 | Peak height | Olfactory bulb | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4171754 | Peak height | Thalamus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4223370 | Peak height | Hypothalamus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4228406 | Peak height | Hypothalamus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4237935 | Peak height | Olfactory bulb | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4238017 | Peak height | Basal ganglia | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4250742 | Peak height | Midbrain | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4275820 | Peak height | Olfactory bulb | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4282562 | Peak height | Midbrain | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4332485 | Peak height | Basal ganglia | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4404985 | Peak height | Cerebral cortex | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4430480 | Peak height | Thalamus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4490719 | Peak height | Hypothalamus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4507249 | Peak height | Midbrain | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4510166 | Peak height | Midbrain | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4526810 | Peak height | Cerebral cortex | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4568819 | Peak height | Basal ganglia | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4580398 | Peak height | Basal ganglia | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4591968 | Peak height | Hypothalamus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4645532 | Peak height | Hypothalamus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4655150 | Peak height | Thalamus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4672417 | Peak height | Midbrain | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4683418 | Peak height | Cerebellum | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4740377 | Peak height | Midbrain | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4747253 | Peak height | Hypothalamus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4800266 | Peak height | Hypothalamus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4814141 | Peak height | Pons | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4832290 | Peak height | Olfactory bulb | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4832925 | Peak height | Thalamus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4891664 | Peak height | Olfactory bulb | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4903751 | Peak height | Olfactory bulb | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4998575 | Peak height | Hypothalamus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5004895 | Peak height | Thalamus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5011444 | Peak height | Olfactory bulb | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5023356 | Peak height | Midbrain | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5040482 | Peak height | Midbrain | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5048473 | Peak height | Midbrain | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5172364 | Peak height | Pons | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5173753 | Peak height | Olfactory bulb | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5229256 | Peak height | Thalamus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5282713 | Peak height | Thalamus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5357535 | Peak height | Thalamus | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5386905 | Peak height | Olfactory bulb | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5399215 | Peak height | Olfactory bulb | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5426280 | Peak height | Hypothalamus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5461021 | Peak height | Midbrain | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5484967 | Peak height | Thalamus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5513612 | Peak height | Pons | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5603080 | Peak height | Olfactory bulb | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5627368 | Peak height | Olfactory bulb | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5647135 | Peak height | Pons | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5738808 | Peak height | Olfactory bulb | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 5875908 | Peak height | Thalamus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 6008278 | Peak height | Hypothalamus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 6136940 | Peak height | Olfactory bulb | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 6172762 | Peak height | Thalamus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 6173145 | Peak height | Midbrain | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 6244844 | Peak height | Midbrain | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 6246711 | Peak height | Medulla | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 6309494 | Peak height | Thalamus | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 6554242 | Peak height | Olfactory bulb | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 6642315 | Peak height | Midbrain | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 7390568 | Peak height | Thalamus | Female |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|